4-nitrophenyl beta-d-xyloside has been researched along with Chondrosteoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aviv, M; Evron, Z; Kollander, Y; Nevo, Z; Robinson, D; Trebicz-Geffen, M; Weinstein, T | 1 |
1 other study(ies) available for 4-nitrophenyl beta-d-xyloside and Chondrosteoma
Article | Year |
---|---|
β-D-xylosides stimulate GAG synthesis in chondrocyte cultures due to elevation of the extracellular GAG domains, accompanied by the depletion of the intra-pericellular GAG pools, with alterations in the GAG profiles.
Topics: Animals; Animals, Newborn; Cell Line; Chondrocytes; Chondroitin Sulfates; Dose-Response Relationship, Drug; Glycosides; Humans; Mice; Naphthalenes; Osteochondroma; Tumor Cells, Cultured | 2012 |